Biophytis SA (ALBPS)

Paris
Currency in EUR
0.1310
-0.0010(-0.76%)
Closed·
ALBPS Scorecard
Full Analysis
Operates with a significant debt burden
ALBPS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.13100.1364
52 wk Range
0.12440.8400
Key Statistics
Edit
Prev. Close
0.131
Open
0.1364
Day's Range
0.131-0.1364
52 wk Range
0.1244-0.84
Volume
105.75K
Average Vol. (3m)
212.43K
1-Year Change
-81.28%
Book Value / Share
-1.22
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ALBPS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Biophytis SA News & Analysis

Show more

Biophytis SA Company Profile

Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. Its therapeutics targets and activates key biological resilience pathways that can protect against and counteract the effects of the multiple biological and environmental stresses, including inflammatory, oxidative, metabolic, and viral stresses that lead to age-related diseases. The company’s lead drug candidate is BIO101, an orally administered small molecule in development to treat neuromuscular diseases, including sarcopenia, Duchenne muscular dystrophy (DMD), and obesity, as well as treatment of severe respiratory failure in patients suffering from COVID-19. It also develops BIO201, an orally administered small molecule for the treatment of retinopathies, including dry age-related macular degeneration, and Stargardt disease. Biophytis SA has a collaboration agreement with AFM-Telethon for the development of its BIO101 for the treatment of DMD. The company was incorporated in 2006 and is headquartered in Paris, France.

Compare ALBPS to Peers and Sector

Metrics to compare
ALBPS
Peers
Sector
Relationship
P/E Ratio
−0.2x−2.5x−0.5x
PEG Ratio
0.000.010.00
Price / Book
−0.5x1.7x2.6x
Price / LTM Sales
-6.5x3.0x
Upside (Analyst Target)
-180.8%52.4%
Fair Value Upside
Unlock16.0%8.7%Unlock

Earnings

Latest Release
May 30, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ALBPS Income Statement

People Also Watch

0.1424
VANTI
+1.71%
0.21
SIGHT
0.00%
5.20
MAAT
-0.38%
0.0722
ALQGC
0.00%
0.08
ALGBE
0.00%

FAQ

What Is the Biophytis SA (ALBPS) Stock Price Today?

The Biophytis SA stock price today is 0.13

What Stock Exchange Does Biophytis SA Trade On?

Biophytis SA is listed and trades on the Paris Stock Exchange stock exchange.

What Is the Stock Symbol for Biophytis SA?

The stock symbol for Biophytis SA is "ALBPS."

What Is the Biophytis SA Market Cap?

As of today, Biophytis SA market cap is 2.90M.

What Is Biophytis SA's Earnings Per Share (TTM)?

The Biophytis SA EPS (TTM) is -5.59.

From a Technical Analysis Perspective, Is ALBPS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Biophytis SA Stock Split?

Biophytis SA has split 1 times.

How Many Employees Does Biophytis SA Have?

Biophytis SA has 22 employees.

What is the current trading status of Biophytis SA (ALBPS)?

As of Jun 22, 2025, Biophytis SA (ALBPS) is trading at a price of 0.13, with a previous close of 0.13. The stock has fluctuated within a day range of 0.13 to 0.14, while its 52-week range spans from 0.12 to 0.84.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.